Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells - PubMed (original) (raw)

Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells

L Klein-Hitpass et al. Nucleic Acids Res. 1991.

Free PMC article

Abstract

Transcriptionally active nuclear extracts from human breast carcinoma cells (T47D) were used to compare the action of progestins and several antiprogestins of the 11 beta-aryl substituted steroid series on the DNA-binding properties and the trans-activating potential of progesterone receptor (PR) in vitro. Using the gel-shift assay we identified a novel type of antiprogestin (ZK98299, type I), which in contrast to type II antiprogestins, including RU486, does not induce binding of PR to progesterone response elements (PREs). In competition experiments excess of type I antiprogestin inhibits induction of DNA binding of PR by progestins and type II antiprogestins suggesting that its binding to PR interferes with the formation of stable receptor dimers. Moreover, we demonstrate that the antagonistic action of ZK98299 can be fully mimicked in vitro by using cell-free nuclear extracts from T47D cells and a 'simple' test promoter. In contrast, type II antiprogestins known to induce certain promoters in vivo exert strong agonistic effects on in vitro transcription of the test template used.

PubMed Disclaimer

References

    1. Cell. 1980 Jun;20(2):353-62 - PubMed
    1. EMBO J. 1990 May;9(5):1603-14 - PubMed
    1. Endocrinology. 1983 Dec;113(6):2195-201 - PubMed
    1. Nature. 1985 Feb 21-27;313(6004):706-9 - PubMed
    1. Endocrinology. 1985 Jun;116(6):2236-45 - PubMed

MeSH terms

Substances

LinkOut - more resources